AGP Executive Report
Last update: 4 minutes agoFDA & Public Health: The Philippines’ FDA is still reviewing Takeda’s Qdenga (TAK-003) anti-dengue vaccine registration, with the health department citing lower efficacy in ages 4–5 and unresolved concerns about severe dengue risk tied to serotype 3. AI & Research Acceleration: The Allen Institute launched a global Brain Health accelerator to map brain cells and circuits behind neurodegenerative disease and speed new treatments. Advanced Materials: TACC (LNJ Bhilwara Group) signed an MoU with NUS’s Institute for Functional Intelligent Materials to push graphene and other functional nanomaterials from lab validation to industrial commercialization. Superconducting Aviation Tech: Strathclyde researchers demonstrated a 100kW fully superconducting aviation motor, aiming for lighter, higher-power propulsion for electric and hydrogen-electric aircraft. MedTech Startup: Uzbekistan’s Lidavex won a Startup World Cup regional stage for CerviLite, a LiDAR-based childbirth data device feeding AI for cervical cancer diagnostics and fertility care. Security for Broadband Users: Vodafone expanded its Secure Net Home and Who’s Home router features to up to 900,000 UK broadband customers. Data Trust for AI: Ataccama was named to Inc.’s Best Workplaces list for 2026, highlighting its role in improving data quality for AI deployments.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
